Boehringer Ingelheim<\/p> \n
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow. Learn more at www.boehringer-ingelheim.com<\/a>.<\/p> \n
鍕冩灄鏍兼鏍肩堪鏄叏鐞冮鍏堢殑鐢熺墿鍒惰嵂浼佷笟锛屽竷灞€浜虹敤鑽搧銆佸姩鐗╀繚鍋ヤ袱澶т笟鍔￠鍩熴€傚叕鍙哥爺鍙戞姇鍏ヤ綅灞呰涓氬墠鍒楋紝鑷村姏浜庣爺绌剁獊鐮存€х枟娉曪紝瑙ｅ喅宸ㄥぇ鏈弧瓒崇殑鍖荤枟闇€姹傦紝浠庤€屽府鍔╂敼鍠勬垨寤堕暱鐢熷懡銆傝嚜1885骞存垚绔嬩互鏉ワ紝鍕冩灄鏍兼鏍肩堪涓€鐩存槸鐙珛鐨勫鏃忎紒涓氾紝濮嬬粓鐫€鐪奸暱杩滃彂灞曪紝灏嗗彲鎸佺画鍙戝睍鐞嗗康璐┛鍏ㄤ环鍊奸摼銆傚叕鍙稿湪鍏ㄧ悆鏈夎秴杩�5.35涓囧悕鍛樺伐锛屾湇鍔￠€�130涓競鍦猴紝鑷村姏浜庢墦閫犱竴涓洿鍋ュ悍銆佹洿鍙寔缁€佹洿鍏钩鐨勬湭鏉ャ€傛洿澶氳鎯咃紝璇疯闂細www.boehringer-ingelheim.com<\/a><\/p> \n